Interesting Research Report on the Future of Neuromodulation Market 2017-2023

1
NEUROMODULATION MARKET GLOBAL INDUSTRY ANALYSIS,
TRENDS, MARKET SIZE AND FORECASTS UP TO 2023
2
A latest report has been added to the wide
database of Neuromodulation Market by Infinium
Global Research. This report studies the
Neuromodulation Market by technology (deep
brain, spinal cord, gastric, sacral, vagus
nerve stimulation), application (chronic pain,
parkinsons disease, dystonia, essential tremor,
gastroparesis, OCD, refractory epilepsy, TRD,
urinary fecal incontinence) market status and
outlook of global and major regions, from
manufacturers, and end industries. The
objective of the study is to identify market
sizes of different segments countries in recent
years and to forecast the values for the next six
years. Neuromodulation Market provides
opportunities in micro markets for stakeholders
to invest along with the detailed analysis of
competitive landscape, latest trends, and
product offerings of the major companies in
the Neuromodulation Market Get a Sample
Request https//www.infiniumglobalresearch.com/re
ports/sample_request/149 Neuromodulation
includes treatments that involve stimulation or
administration of medications directly to the
bodys nervous system for therapeutic purposes.
The target cells for stimulation include nerves
in the central and peripheral nervous systems,
the autonomic nervous system, and the
deep cell nuclei of the brain,
resulting in modulation of their
activity. Neuromodulation includes several
modalities, and is a cross-disciplinary approach
to pain control and neurologic dysfunction.
Neuromodulation can be used to treat movement
disorders, spasticity, and epilepsy, as well as
pain syndromes. Devices are implanted which can
either include drug delivery pumps or
neural stimulators. The most common type is
spinal cord stimulation, which is used for back
or lower extremity pain. Spinal cord stimulation
involves electrical stimulation of the spinal
cord to interrupt pain signals from the spinal
cord to the brain, and to trade a painful
sensation with a more pleasant tingling
sensation. The technology has been present
since the 1960s and in the past decade
has become highly effective in the treatment
of pain. In addition to chronic pain
relief, other neuromodulation treatments now
used include deep brain stimulation for
essential tremor, Parkinsons disease,
dystonia, epilepsy and disorders such as
depression, obsessive compulsive disorder and
Tourette syndrome sacral nerve stimulation
for pelvic disorders and incontinence
gastric and colonic stimulation for
gastrointestinal disorders such as dysmotility or
obesity vagus nerve stimulation for epilepsy,
obesity or depression carotid artery stimulation
for hypertension and spinal cord stimulation for
ischemic disease such as angina and peripheral
vascular disease.
3
Market Insights Rise in base of geriatric
population, increasing number of patients with
neurological disorders, strong product pipeline
with various innovations, increasing number
of target applications, and increasing
demand from emerging countries are the
primary driving factors contributing for the
growth of this market. Neuromodulation is
reversible and adjustable, in which physicians
can on-invasively manage the electrical
parameters with a programmer to effectively
control disease symptoms. However, there are
certain factors which could hamper the
growth of this market, includes unfavorable
reimbursement scenario and lack of sufficient
number of trained professionals to treat
disorders. Make an Enquiry https//www.infiniumgl
obalresearch.com/reports/enquiry/149 Segment
Covered The report on global neuromodulation
market covers segments such as, technology
and application. On the basis of technology
the global neuromodulation market is
categorized into deep brain stimulation,
spinal cord stimulation, gastric stimulation,
sacral nerve stimulation, vagus nerve
stimulation and others. On the basis
of application the global neuromodulation
market is categorized into chronic pain,
parkinsons disease, dystonia, essential
tremor, gastroparesis, obsessive compulsive
disorder (OCD), refractory epilepsy, treatment
resistant depression (TRD), urinary fecal
incontinence and other applications. Geographic
Coverage The report provides regional analysis
covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In
this section the key trends and market size for
each geography is provided over the period of
2015-2023. The countries covered in the North
America region include the U.S., Canada, and
Mexico while Asia-Pacific includes China, Japan,
India, South Korea, Malaysia, and among
others. Moreover, Germany, U.K., France,
Spain, and Rest of Europe are included in the
European region. The U.S. drives the growth in
the North America region as it is the largest
market in the region. The Asia-pacific region
offers a substantial potential for the market
growth owing to rapid growth in markets such as
India and China. The APAC region is projected to
experience a growth at a CAGR of x.x over the
period of 2017-2023.
4
Companies Profiled The report provides profiles
of the companies in the global neuromodulation
market such as, Medtronic plc, Boston
Scientific Corporation, St. Jude Medical,
Cyberonics, Cochlear Ltd., Advanced Bionics,
Sonova Group, Nevro Corporation, Neuronetics,
Inc. and Greatbatch. Report Highlights The
report provides deep insights on demand
forecasts, market trends and micro and macro
indicators. In addition, this report provides
insights on the factors that are driving and
restraining the global neuromodulation market.
Moreover, IGR-Growth Matrix analysis given in the
report brings an insight on the investment areas
that existing or new market players can consider.
The report provides insights into the market
using analytical tools such as Porter's five
forces analysis and DRO analysis of
neuromodulation market. Moreover, the study
highlights current market trends and provides
forecast from 2017-2023. We also have highlighted
future trends in the neuromodulation market that
will impact the demand during the forecast
period. Moreover, the competitive analysis given
in each regional market brings an insight on the
market share of the leading players. This report
will help manufacturers, suppliers and
distributors of the neuromodulation market to
understand the present and future trends in this
market and formulate their strategies
accordingly. Click the Below Full Report Link
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/global_neuromodulation_market